During the past decade, Allen Yeoh Eng Juh conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allen Yeoh Eng Juh" are "CAR" (2 trials), "CAR T-Cell-Related Encephalopathy Syndrome" (2 trials), "Lymphoblastic Leukemia" (2 trials), "Lymphoblastic Leukemia in Children" (2 trials) and "Lymphoblastic Leukemia, Acute Adult" (2 trials). Many other conditions were trialed in "Allen Yeoh Eng Juh" in a lesser frequency.

Most popular intervention types in "Allen Yeoh Eng Juh" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "CAR T-cell therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Allen Yeoh Eng Juh" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Allen Yeoh Eng Juh". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Allen Yeoh Eng Juh, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allen Yeoh Eng Juh, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".